SARS-CoV-2 Infection Boosts MX1 Antiviral Effector in COVID-19 Patients

In a published case-control study (GSE152075) from SARS-CoV-2-positive (n = 403) and -negative patients (n = 50), we analyzed the response to infection assessing gene expression of host cell receptors and antiviral proteins. The expression analysis associated with reported risk factors for COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Bizzotto, Juan, Sanchis, Pablo, Abbate, Mercedes, Lage-Vickers, Sofía, Lavignolle, Rosario, Toro, Ayelén, Olszevicki, Santiago, Sabater, Agustina, Cascardo, Florencia, Vazquez, Elba, Cotignola, Javier, Gueron, Geraldine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510433/
https://www.ncbi.nlm.nih.gov/pubmed/32989429
http://dx.doi.org/10.1016/j.isci.2020.101585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510433/
https://www.ncbi.nlm.nih.gov/pubmed/32989429
http://dx.doi.org/10.1016/j.isci.2020.101585

Ejemplares similares